En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal aguda severa y los eventos renales mayores a 90 días Hipótesis: magnesio mejora secreción tubular de cisplatino JAMA Oncol 2025 10.1001/jamaoncol.2025.0756 https://t.co/WlvTi9cnhk
Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Apr 2025 – Sep 2025Where it's discussed
-
X / Twitter194 posts
-
News15 articles
-
YouTube2 videos
-
Blogs2 articles
-
Bluesky1 posts
AI synopsis
What people are saying
The discussions highlight critical points from the research, such as a 20% reduction in kidney injury risk with IV magnesium and its application in various patient groups, evidenced by phrases like 'a simple move, a big impact' that suggest the findings are both straightforward and powerful. Additionally, users express surprise at the lack of implementation in some U.S. facilities, using phrases like 'I was surprised,' indicating a belief in the importance and urgency of adopting these practices based on the study's findings.
The majority of discussions express strong support for the findings related to the effectiveness of IV magnesium in reducing kidney injury risk.
Participants show a high level of curiosity regarding the implications of the study, often referencing the significance of the results.
Many comments delve into specific details about the research, such as percentage reductions in kidney injury and recommendations for clinical practice.
There is a consensus that the publication could significantly influence clinical practices and guidelines for cancer treatment involving cisplatin.
Abstract in brief
- The study investigates the effectiveness of intravenous (IV) magnesium in preventing acute kidney injury (CP-AKI) in cancer patients undergoing cisplatin chemotherapy.
- Conducted across 5 major cancer centers in the US, it included over 13,000 patients to assess the impact of IV magnesium on kidney health and overall mortality rates.
- Findings indicated that patients receiving IV magnesium had lower rates of CP-AKI or death compared to those who did not, suggesting that IV magnesium could be a beneficial preventive measure in clinical settings.
Top posts
Most liked on X and BlueskyProphylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI) in patients with cancer undergoing cisplatin chemotherapy. https://t.co/Al9FpH395g https://t.co/wjl1ly4dfE
シスプラチン使用時のマグネシウム投与は、腎障害を予防する。常識かと思ってたんですが、米国でもやっていない施設も意外と多いのにびっくりhttps://t.co/LCsAsseqUJ
Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury (CP-AKI) from @ShrutiGkidney @DavidLeaf9 @kdjhaveri @JAMAOnc #Nephpearls #Onconephrology
Podcast--Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury https://t.co/StCBTnhheF @ShrutiGkidney
Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury https://t.co/TtZvfoBCwr @kdjhaveri , @jam_hirsch and led by @DavidLeaf9, @ShrutiGkidney @Api_chew, @M_Abramson @BWHkidney @MSK_Neph @ISMMSKidney @MDAndersonNews @CU_Kidney @HofNorthwellDOM @JAMAOnc
All mentions
Evaluating Intravenous Magnesium for Kidney Injury Prevention
This video features an interview with Dr. Shruti Gupta, discussing her research on the effectiveness of intravenous magnesium in preventing acute kidney injury in cancer patients undergoing cisplatin chemotherapy. The…
Mg to Prevent Cisplatin Kidney Injury
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @dragibert: Prevención de la nefrotoxicidad por cisplatino mediante magnesio EV. Una buena medida para nuestras pacientes con cáncer de…
Prevención de la nefrotoxicidad por cisplatino mediante magnesio EV. Una buena medida para nuestras pacientes con cáncer de cérvix y de ovario. https://t.co/CYa5jUjNTL @JAMAOnc @asociacionASACO
Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury https://t.co/10q2AnL2Fk
RT @MLPOncoData: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury https://t.co/lw6I5lbB5c
RT @Office_j: 【備忘】Jul 08 CKJ誌に「シスプラチン腎毒性予防におけるマグネシウムの役割にさらなるエビデンス」と題する論説。Gupta S et al. JAMA Oncol [https://t.co/GeezqFeGWz] を評価。 https:/…
【備忘】Jul 08 CKJ誌に「シスプラチン腎毒性予防におけるマグネシウムの役割にさらなるエビデンス」と題する論説。Gupta S et al. JAMA Oncol [https://t.co/GeezqFeGWz] を評価。 https://t.co/P3ryAG5P3z [Free]
RT @MLPOncoData: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury https://t.co/lw6I5lbB5c
RT @JAMAOnc: Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI)…
RT @JAMAOnc: Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI)…
RT @JAMAOnc: Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI)…
RT @JAMAOnc: Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI)…
Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury https://t.co/lw6I5lbB5c
RT @JAMAOnc: Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI)…
RT @JAMAOnc: Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI)…
RT @JAMAOnc: Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI)…
RT @JAMAOnc: Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI)…
RT @JAMAOnc: Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI)…
RT @JAMAOnc: Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI)…
RT @JAMAOnc: Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI)…
RT @JAMAOnc: Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI)…
RT @JAMAOnc: Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI)…
RT @JAMAOnc: Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI)…
RT @JAMAOnc: Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI)…
RT @JAMAOnc: Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI)…
RT @JAMAOnc: Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI)…
RT @JAMAOnc: Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI)…
RT @JAMAOnc: Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI)…
RT @JAMAOnc: Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI)…
RT @JAMAOnc: Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI)…
RT @JAMAOnc: Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI)…
RT @JAMAOnc: Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI)…
RT @JAMAOnc: Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI)…
RT @JAMAOnc: Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI)…
Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI) in patients with cancer undergoing cisplatin chemotherapy. https://t.co/Al9FpH395g https://t.co/wjl1ly4dfE
RT @BatistaTP: I have strongly advocate for supplemental Mg++ against AKI during HIPEC. Among 13 719 pct treated w/ IV CDDP, IV Mg++ was a…
I have strongly advocate for supplemental Mg++ against AKI during HIPEC. Among 13 719 pct treated w/ IV CDDP, IV Mg++ was associated w/ 20% lower adjusted odds of developing AKI. Findings also supported by multiple sensitivity and secondary analyses! https://t.co/iURzQJ65b7
Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury https://t.co/9pmX0t57eb
RT @edgarvlermamd: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury (CP-AKI) from @ShrutiGkidney @DavidLeaf9 @kdjhaveri @…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @Katsumata_Nori: シスプラチン使用時のマグネシウム投与は、腎障害を予防する。常識かと思ってたんですが、米国でもやっていない施設も意外と多いのにびっくりhttps://t.co/LCsAsseqUJ
RT @Katsumata_Nori: シスプラチン使用時のマグネシウム投与は、腎障害を予防する。常識かと思ってたんですが、米国でもやっていない施設も意外と多いのにびっくりhttps://t.co/LCsAsseqUJ
RT @Katsumata_Nori: シスプラチン使用時のマグネシウム投与は、腎障害を予防する。常識かと思ってたんですが、米国でもやっていない施設も意外と多いのにびっくりhttps://t.co/LCsAsseqUJ
RT @Katsumata_Nori: シスプラチン使用時のマグネシウム投与は、腎障害を予防する。常識かと思ってたんですが、米国でもやっていない施設も意外と多いのにびっくりhttps://t.co/LCsAsseqUJ
RT @Katsumata_Nori: シスプラチン使用時のマグネシウム投与は、腎障害を予防する。常識かと思ってたんですが、米国でもやっていない施設も意外と多いのにびっくりhttps://t.co/LCsAsseqUJ
RT @Katsumata_Nori: シスプラチン使用時のマグネシウム投与は、腎障害を予防する。常識かと思ってたんですが、米国でもやっていない施設も意外と多いのにびっくりhttps://t.co/LCsAsseqUJ
RT @Katsumata_Nori: シスプラチン使用時のマグネシウム投与は、腎障害を予防する。常識かと思ってたんですが、米国でもやっていない施設も意外と多いのにびっくりhttps://t.co/LCsAsseqUJ
シスプラチン使用時のマグネシウム投与は、腎障害を予防する。常識かと思ってたんですが、米国でもやっていない施設も意外と多いのにびっくりhttps://t.co/LCsAsseqUJ
RT @RClaure_nefro: Intravenous magnesium and cisplatin associated AKI https://t.co/PrlWZ7LrTM
【シスプラチン関連AKIに対する予防的IV Mg】
RT @RClaure_nefro: Intravenous magnesium and cisplatin associated AKI https://t.co/PrlWZ7LrTM
Intravenous magnesium and cisplatin associated AKI https://t.co/PrlWZ7LrTM
RT @edgarvlermamd: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury (CP-AKI) from @ShrutiGkidney @DavidLeaf9 @kdjhaveri @…
Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury https://t.co/MYgemiH35V
Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury https://t.co/zjHgkzVNHs
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury - Sergio Cifuentes (@Onco_Cifu88) https://t.co/CBJxo6XDbf #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #KidneyInjury https://t.co/koF4BkK3Yf
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury https://t.co/ghSRdiYzg3
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
RT @JonathanNefro: En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal…
En quimioterapia con cisplatino, 28% recibió magnesio 2gr IV profiláctico; se asoció a ↓20% en el riesgo de lesión renal aguda severa y los eventos renales mayores a 90 días Hipótesis: magnesio mejora secreción tubular de cisplatino JAMA Oncol 2025 10.1001/jamaoncol.2025.0756 https://t.co/WlvTi9cnhk
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @edgarvlermamd: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury (CP-AKI) from @ShrutiGkidney @DavidLeaf9 @kdjhaveri @…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @edgarvlermamd: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury (CP-AKI) from @ShrutiGkidney @DavidLeaf9 @kdjhaveri @…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
Intravenous Mg and Cisplatin-Associated Acute Kidney Injury El Mg IV debería priorizarse en: - Mujeres <65 años con eGFR ≥90 y Mg sérico basal de 2.0–2.2 mg/dL. - Pacientes que reciben dosis bajas de cisplatino (<50 mg). - Diabéticos
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @edgarvlermamd: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury (CP-AKI) from @ShrutiGkidney @DavidLeaf9 @kdjhaveri @…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @edgarvlermamd: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury (CP-AKI) from @ShrutiGkidney @DavidLeaf9 @kdjhaveri @…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @edgarvlermamd: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury (CP-AKI) from @ShrutiGkidney @DavidLeaf9 @kdjhaveri @…
RT @edgarvlermamd: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury (CP-AKI) from @ShrutiGkidney @DavidLeaf9 @kdjhaveri @…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @edgarvlermamd: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury (CP-AKI) from @ShrutiGkidney @DavidLeaf9 @kdjhaveri @…
RT @edgarvlermamd: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury (CP-AKI) from @ShrutiGkidney @DavidLeaf9 @kdjhaveri @…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @DrYukselUrun: A simple move, a big impact: Giving IV magnesium before cisplatin cut kidney injury risk by 20%! Safe. Cheap. Available.…
RT @edgarvlermamd: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury (CP-AKI) from @ShrutiGkidney @DavidLeaf9 @kdjhaveri @…
RT @edgarvlermamd: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury (CP-AKI) from @ShrutiGkidney @DavidLeaf9 @kdjhaveri @…
RT @edgarvlermamd: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury (CP-AKI) from @ShrutiGkidney @DavidLeaf9 @kdjhaveri @…
RT @edgarvlermamd: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury (CP-AKI) from @ShrutiGkidney @DavidLeaf9 @kdjhaveri @…
RT @edgarvlermamd: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury (CP-AKI) from @ShrutiGkidney @DavidLeaf9 @kdjhaveri @…
RT @edgarvlermamd: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury (CP-AKI) from @ShrutiGkidney @DavidLeaf9 @kdjhaveri @…
RT @edgarvlermamd: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury (CP-AKI) from @ShrutiGkidney @DavidLeaf9 @kdjhaveri @…
RT @edgarvlermamd: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury (CP-AKI) from @ShrutiGkidney @DavidLeaf9 @kdjhaveri @…
RT @HofstraKidney: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury https://t.co/TtZvfoBCwr @kdjhaveri , @jam_hirsch and…
RT @edgarvlermamd: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury (CP-AKI) from @ShrutiGkidney @DavidLeaf9 @kdjhaveri @…
Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury (CP-AKI) from @kdjhaveri.bsky.social #Nephpearls #Onconephrology
Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury (CP-AKI) from @ShrutiGkidney @DavidLeaf9 @kdjhaveri @JAMAOnc #Nephpearls #Onconephrology
RT @HofstraKidney: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury https://t.co/TtZvfoBCwr @kdjhaveri , @jam_hirsch and…
RT @kdjhaveri: Podcast--Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury https://t.co/StCBTnhheF @ShrutiGkidney
RT @HofstraKidney: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury https://t.co/TtZvfoBCwr @kdjhaveri , @jam_hirsch and…
RT @kdjhaveri: Podcast--Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury https://t.co/StCBTnhheF @ShrutiGkidney
RT @kdjhaveri: Podcast--Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury https://t.co/StCBTnhheF @ShrutiGkidney
RT @HofstraKidney: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury https://t.co/TtZvfoBCwr @kdjhaveri , @jam_hirsch and…
RT @kdjhaveri: Podcast--Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury https://t.co/StCBTnhheF @ShrutiGkidney
RT @HofstraKidney: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury https://t.co/TtZvfoBCwr @kdjhaveri , @jam_hirsch and…
RT @kdjhaveri: Podcast--Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury https://t.co/StCBTnhheF @ShrutiGkidney
RT @kdjhaveri: Podcast--Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury https://t.co/StCBTnhheF @ShrutiGkidney
Podcast--Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury https://t.co/StCBTnhheF @ShrutiGkidney
RT @HofstraKidney: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury https://t.co/TtZvfoBCwr @kdjhaveri , @jam_hirsch and…
RT @JAMAOnc: Listen to an interview with Shruti Gupta, MD, MPH, author of "Intravenous Magnesium and Cisplatin-Associated Acute Kidney Inju…
RT @HofstraKidney: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury https://t.co/TtZvfoBCwr @kdjhaveri , @jam_hirsch and…
Listen to an interview with Shruti Gupta, MD, MPH, author of "Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury" hosted by @VivekSubbiah. https://t.co/o9XMcOjvaV
RT @tuttsakhil: Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury @JAMAOnc https://t.co/9P9UGdSaWk
Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury https://t.co/TtZvfoBCwr @kdjhaveri , @jam_hirsch and led by @DavidLeaf9, @ShrutiGkidney @Api_chew, @M_Abramson @BWHkidney @MSK_Neph @ISMMSKidney @MDAndersonNews @CU_Kidney @HofNorthwellDOM @JAMAOnc
Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury @JAMAOnc https://t.co/9P9UGdSaWk